4D pharma

NASDAQ: LBPS · Real-Time Price · USD
1.65
0.00 (0.00%)
At close: Apr 24, 2025, 3:47 PM

4D pharma Income Statement

Financials in GBP. Fiscal year is January - December.
Fiscal Year FY 2021
Period Ending Dec 31, 2021
Revenue
718K
Cost of Revenue
n/a
Gross Profit
718K
Operating Income
-31.38M
Interest Income
1K
Pretax Income
-31.96M
Net Income
-31.94M
Selling & General & Admin
15.89M
Research & Development
21.63M
Other Expenses
n/a
Operating Expenses
37.52M
Interest Expense
581K
Selling & Marketing Expenses
n/a
Cost & Expenses
37.52M
Income Tax Expense
-22K
Shares Outstanding (Basic)
13.44M
Shares Outstanding (Diluted)
13.44M
EPS (Basic)
-2.4
EPS (Diluted)
-2.4
EBITDA
-30.03M
EBIT
-31.38M
Depreciation & Amortization
1.35M